CAPITATION

联合基金（750 000美元）。联合体供资部分用于偿还 研究基地以及没有自己的CCOP的中北部癌症治疗组成员研究中心 格兰特.该资金按NIH规定的费率提供;目前每个病例信贷为2，000美元， 仅限于按人头报销癌症控制方案。预测为此所需的资金总额 补助金的组成部分取决于许多变量，例如新协议的上线、关闭 现有方案以及参与研究中心的应计活动。本文件要求提供资金， 支持所有非CCOP NCCTG站点的375个应计项目，目前每个项目2，000美元， 75万美元。

Consortium Funds ($750,000). The consortium funding component is utilized to provide reimbursement at the research base as well as at North Central Cancer Treatment Group member sites not having their own CCOP grant. This funding is provided at the rate specified by the NIH; currently $2,000 per case credit, and is restricted to capitation reimbursement for cancer control protocols. Predicting the total funding needed for this component of the grant is dependent on numerous variables such as new protocols coming on-line, closing of existing protocols, and the accrual activity of participating sites. Funding is requested for this submission to support 375 total accruals at all non-CCOP NCCTG sites at the current rate of $2,000 each, for a total request of $750,000.